did serena williams really use glp 1 on Her Experience With a GLP-1 Weight Loss Drug Why Serena Williams is facing

Tirzepatide is a dual-acting medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

New data for alcohol and nicotine use disorders are positive, still emerging, and there is also hope about GLP treatment for cannabis use disorder (CUD), which has accelerated quickly

I also think that the state could be negotiating with the companies to kind of try to bring down the cost. Young added that the state does not take enough preventative measures, and weight loss medications can help minimize other conditions West Virginians may struggle with

A November 2025 KFF Health Tracking Poll found that roughly 1 in 8 U.S